Moreover, programmed cell death protein 1(PD-1) showed increased expressed in TIL [30] and peripheral CD4+ and CD8+ T-lymphocytes [31] Based on this result, the inhibition of the PD-1/PDL-1 interaction would lead to a decreased tumor burden in osteosarcoma-bearing mice [32]. Here, CD8A is linked to osteosarcoma.